IDS Flashcards
Fever without a focus definition
Rectal temperature of 38C or higher as the sole presenting feature
Common pathogens in late-onset neonatal bacterial disease
Group B streptococci
E. coli
Listeria monocytogenes
Most common serious bacterial infection in 1-3 age group and most common pathogen
Pyelonephritis
E. coli
Low risk criteria for child 1-3 mo old with fever
CBC <15,000-20,000 Band:total ratio <0.2, absolute band ≤1,500 Urine <9-10 WBC CSF <5-10 WBC Stool <5 WBC
Pathogens that account for most cases of occult bacteremia in 3-36 mo age group
S. pneumoniae
N. meningitidis
Salmonella
Classic FUO
> 38C
3 weeks as outpatient, >2 visits
1 week in the hospital
Virulence factors:
slime layer, coagulase, Protein A, catalase, penicillinase, B-lactamase, Panton-Valentine leukocidin, exfoliatin A and B, TSST-1, altered PBP-2A
Staphylococcus aureus
Produces a yellow or orange pigment and B-hemolysis on blood agar
Staphylococcus aureus
Most common cause of osteomyelitis and suppurative arthritis in children
Staphylococcus aureus
Virulence factor responsible for methicillin resistance of MRSA isolates
altered PBP-2A
Common pathogens in cavitary pneumonia
S. aureus, M tuberculosis, K. pneumoniae
Treatment of TSS
B-lactamase resistant antistaphylococcal antibiotic (nafcillin, oxacillin, first gen cephalosporin) PLUS clindamycin (to reduce toxin production
Most common cause of nosocomial bacteremia
S. epidermidis
Most common pathogen associated with CSF shunt meningitis
coagulase-negative staphylococci
Gram-positive, lancet-shaped, diplococci
Streptococcus pneumoniae
On solid media, forms unpigmented, umbilicated colonies surrounded by a zone of incomplete a hemolysis.
Bile soluble and Optochin-sensitive
Streptococcus pneumoniae
Average time to isolation is 14-15 hr
Gram-positive coccoid-shaped bacteria that tend to grow in chains
Zone of complete hemolysis that surrounds colonies grown in blood agar
Sensitive to bacitracin
Group A b-hemolytic streptococcus (S. pyogenes)
Rash appears 24-48 hours after onset of symptoms and begins to fade after 3-4 days
Starts around the neck and spreads over the trunk and extremities
Goose-pimple appearance
Strawberry tongue
Scarlet fever
Pathogen in bullous impetigo
S. aureus
Pathogen in nonbullous impetigo
GAS
Most common cause of acute pharyngitis in children
viruses
Most common cause of bacterial pharyngitis
GAS
Treatment of perianal streptococcal disease
oral cefuroxime
Latent period between GAS pharyngitis and poststreptococcal reactive arthritis
<10 days
Involves large joints, and small peripheral joints as well as the axial skeleton
Not migratory
Rheumatogenic GAS serotypes
M types 1, 3, 5, 6, 18, 29
Age of greatest risk for GAS pharyngitis
5-15 yr
Also highest incidence of both initial attacks and recurrences of acute rheumatic fever
Antiinflammatory therapy for arthritis with carditis without cardiomegaly or CHF
aspirin 50-70 mkday in QID x 3-5 days
then 50 mkday QID x 3 weeks
then half that dose for 2-4 weeks
Antiinflammatory therapy for arthritis with carditis, cardiomegaly, CHF
prednisone 2 mkday QID x 2-3 weeks then half the dose for 2-3 weeks then taper by 5 mg/24 hr every 2-3 days When tapering prednisone, start asprin at 50 mkday QID x 6 weeks
Treatment for Sydenham chorea
phenobarbital 16-32 mg q6-8
If ineffective,
haloperidol 0.01-0.03 mkday BID pr
chlorpromazine 0.05 mkdose q4-6
Secondary prophylaxis for recurrences of ARF
Benzathine penicillin G 600,000 IU IM for ≤60 lb, 1,200,000 IU IM for >60 lb q21-28 days
or
Pen V 250 mg BI
or
Sulfadiazine or sulfisoxazole 0.5 g OD ≤60 lb or 1 g for >60 lb
Duration of secondary prophylaxis for ARF
- Rheumatic fever without carditis
- RF with carditis but without residual heart disease
- RF with carditis and residual heart disease
- RF w/o carditis: 5 years or until 21 yr
- RF with carditis, no residual heart disease: 10 yr or until 21 yr
- RF w/ carditis, with residual heart disease: 10 yr or until 40 yr, SOMETIMES FOR LIFE
Facultative anaerobic gram-positive cocci that form chains or diplococci in broth
Forms small gray-white colonies on solid medium
B-hemolytic, resistant to bacitracin and TMP-SMX
CAMP factor
Group B streptococcus
S. agalactiae
Vaginorectal GBS screening should be performed for all pregnant women ___ gestation
35-37 wk
Gram-positive, catalase-negative, facultative anaerobes that grown in pairs or short chains
Nonhemolytic on sheep blood agar
Able to grow in bile and hyrolyze esculin
Can grow in 6.5% NaCl and hydrolyze L-pyrrolidonyl-B-naphthylamide
Enterococcus
Aerobic, nonencapsulated, non-spore-forming, nonmotile, pleomorphic, GRAM POSITIVE BACILLI
Isolated in cystine-tellurite blood agar or Tinsdale agar - gray-black colonies
Urease negative
Elek test
Corynebacterium diphtheriae
62-kDa polypetide exotoxin
Diphtheria virulence factor
Inhibits protein synthesis and causes local tissue necrosis
Incubation period of diphtheria
2-4 days
The first evidence of cardiac toxicity occurs during the __ week of illness in diphtheria
2nd and 3rd
ECG findings in diphtheria toxic cardiomyopathy
prolonged PR interval
ST-T wave changes
dysrhythmias
In diphtheria, cranial neuropathies occur in the __ week, leading to oculomotor and ciliary paralysis
5th
Onset of symmetric polyneuropathy in diphtheria
10 days to 3 months after oropharyngeal infection
Distal weakness with proximal progression
Antimicrobial therapy for diphtheria
erythromycin 40-50 mkday IV/PO q6, max 2g/d
OR Pen G 100-150T ukd IV q6
OR daily procaine penicillin
<10 kg 300T u/d IM; >10 kg 600T u/d x 14 d
Antimicrobial prophylaxis for case contacts of diphtheria
Benzathine penicillin G
<6 yr: 600T u IM, >6 yr 1.2M u IM
OR erythromycin 40-50 mkday WID x 10d
Facultative anaerobic, non-spore-forming, motile, gram-positive bacilli
Catalase positive
tumbling motility, umbrella-type formation
grows at cold temp 4-10C
Listeria
Iron overload syndromes have high risk for __ because of sideraphores that scavenge iron
Listeriosis
Differentiate two clinical presentations for neonatal listeriosis
Early onset <5 days, septicemic form
Late-onset >5 days, mean 14 days, meningitic form
CBC findings in listeriosis
monocytosis or lymphocytosis
Treatment for listeriosis
ampicillin 100-200, up to 400 for meningitis mkday q6 alone or in combination with aminoglycoside 5-7.5 mkday q8
duration: 2-3 weeks
Actinomycosis in children suggests an underlying immunodeficiency, especially?
chronic granulomatous disease
Anaerobic, nonsporulating, gram-positive bacteria with a filamentous branching structure
Cultures in 24-48 hr
Forms loose masses of delicate branching filaments, with a characteristic spider-like growth
Does not stain with acid-fast stain
Actinomyces israelii
Sulfur granules - adherent mass of PMN attached to the radially arranged eosinophlic clubs of the granule on H&E staining - are characteristic of?
Actinomycosis
Chronic, granulomatous, suppurative disease characterized by direct extension to contiguous tissue across natural anatomic barriers with the formation of numerous draining fistulas and sinus tracts
actinomycosis
Lumpy jaw
actinomycosis
Chronic lower lobe pulmonary consolidation
Empyema
Wavy periostitis of the ribs
radiographic triad of thoracic actinomycosis
Treatment for actinomycosis
Penicillin G 250T ukday q4-6, max 18-24M u/day x 2-6 wk, followed by oral antibiotics for 3-12 mo
Penicillin V 100 mkday q6
Delicately branched, gram-positive, coccoid to bacillary bacteria that tend to fragment
Filamentous, obligate aerobe
Forms waxy, folded, or heaped colonies at the edges after 1-2 wk
Fragmented bacilli with stain concentrated in a beaded pattern along portions of the branching filaments with Kinyoun acid-fast staining
Nocardia
Treatment for nocardiosis
Trimethoprim-sulfamethoxazole
ampicillin and co-amox for N. brasiliensis
Superficial cutaneous 6-12 wk
6-12 mo for mycetoma, pulmonary, systemic
Gram-positive, fastidious, encapsulated, oxidase-positive, aerobic diplococus.
Neisseria meningitidis
Adrenal insufficiency caused by adrenal necrosis/hemorrhage in meningococcus
Waterhouse-Friedrichsen syndrome
Antibiotic treatment of meningococcemia
Penicillin G 300T umkday q4-6, max 12-14M
or ampicillin 200-400 mkday q6
or cefotaxime 200-300 mkday q6-8 (neonate)
or ceftriaxone 100 mkday q12-24
Most common complication of acute severe meningococcal septicemia
focal skin infarction
Antibiotic prophylaxis to prevent N. meningitidis infection
Rifampin Infants <1 mo: 5 mkdose q12 x 2 days Children >1 mo: 10 mkdose q12 x 2 days Ceftriaxone <15 yr: 125 mg IM x 1 dose >15 yr: 250 mg IM x 1 dose Ciprofloxacin >1 mo: 20 mkdose x 1 dose
Nonmotile, aerobic, non-spore-forming, gram-negative, intracellular diplococcus with flattened adjacent surfaces
Thayer-Martin growth medium
Produces cytochrome oxidase
Neisseria gonorrhoeae
Most common sexually transmitted infection found in sexually abused children
Gonorrhea
Perihepatitis resulting from dissemination of gonococci from the fallopian tubes through the peritoneum to the liver capsule
Fitz-Hugh-Curtis syndrome
Two clinical syndromes of disseminated gonococcal infection
- Tenosynovitis-dermatitis syndrome
2. Suppurative arthritis syndrome
Painful, discrete, 1-20 mm pink or red macules that progress to maculopapular, vesicular, bullous, pustular or petechial lesions are dermatologic lesions associated with what pathogen?
Neisseria gonorrhoeae
Necrotic pustule on an erythematous base, including the palmar and plantar surfaces, sparing the face and scalp, numbering between 5 and 40
Neisseria gonorrhoeae
Antibacterial treatment for uncomplicated gonorrhea
Ceftriaxone 250 mg IM
Infant and children: 50 mkdose, max 125 mg
plus azithromycin 1 g PO x 1 dose
or doxycycline 100 mg PO BID x 7 days
Treatment for disseminated gonococcal infection
ceftriaxone 1 g/day x 7-14 days
Infant and children: 50 mkday max 1g
plus azithromycin 1 g PO x 1 dose
or doxycycline 100 mg PO BID x 7 days
Fastidious gram-negative, pleomorphic coccobacillus
H. influenzae
Most important known element of host defense against H. influenzae
Anti-PRP antibody
Treatment for H. influenzae meningitis
Ampicilli, cefotaxime or ceftriaxone
for 7-14 days
Dexamethasone 0.6 mkday q6 x 2 days
Duration of treatment for H. influenzae
- cellulitis
- preseptal cellulitis
- orbital cellulitis
- Supraglottitis/acute epiglottitis
- pneumonia
- suppurative arthritis
- cellulitis: 7-10 days, shift to oral once afebrile
- preseptal cellulitis: 5 days IV, 10 days total
- orbital cellulitis: 14 days IV
- supraglottis/epiglottitis: 7 days, shift to oral once able to take fluids by mouth
- pneumonia: 7-10 days
- suppurative arthritis: 5-7 days IV, 3 wk total or until normal CRP
H. influenzae prophylaxis
rifampin 0-1 mo 10 mkdose OD x 4 days
>1 mo 20 mkdose max 600 mg OD x 4 days
Small, fastidious, gram-negative coccobacilli
Colonize only ciliated epithelium
Bordetella
Virulence factors: filamentous hemagglutinin, agglutinogens, pertactin, tracheal cytotoxin, dermonecrotic factor
B. pertussis
Incubation period of B. pertussis
3-12 days
Stages of pertussis
- catarrhal stage (1-2 wk)
- paroxysmal stage (2-6 wk)
- convalescent stage (≥2 wk)
Cough of 14 days or longer
At least 1 associated symptom of paroxysms, whoop or posttussive vomiting. Consideration?
Pertussis
Infant younger than 3 mo, with gagging, gasping, apnea, cyanosis, apparent life-threatening event. Consideration?
Pertussis
Features of a non-life-threatening paroxysm 1. duration 2. color change 3. HR, O2 sat 4. 5. 6.
- Duration <45 sec
- Red but not blue color change
- tachycardia, bradycardia (not <60 in infants), or desaturation resolve spontaneously at the end of the paroxysm
- Brisk self-rescue
- Self-expectorated mucus plug
- Posttusive exhaustion but not unresponsiveness
Antimicrobial treatment for pertussis, <1 mo
azithromycin 10 mkday OD x 5 days
Antimicrobial treatment for pertussis, 1-5 mo
azithromycin 10 mkday OD x 5 days
or erythromycin 40-50 mkday QID x 14d
or clarithromycin 15 mkday BID x 7d
or TMP-SMZ
Antimicrobial treatment for pertussis, ≥6 mo
azithromycin 10 mkday OD max 500 on D1
then 5 mkday max 250 on D2-5
or erythromycin 40-50 mkday QID x 14d
or clarithromycin or TMP-SMZ
Optimal time to give Tdap to pregnant women
26-37 w AOG, every pregnancy
Motile, nonsporulating, nonencapsulated, gram negative rods
Resistant to many physical agents but can be killed by heating to 54.4C for 1 hr or 60C for 15 min
Salmonellae
Number of NTSbacteria to cause symptomatic disease in a healthy adult
Incubation period
10^6-10^8
Incubation period 6-72 hr (mean 24 hr)
Children with what hematologic disorder are at increased risk for Salmonella septicemia and osteomyelitis
sickle cell disease
Treatment of Salmonella gastroenteritis
For <3 mo or immunocompromised cefotaxime 100-200 mkday q6-8 x 5-14 days or ceftriaxone 75 mkday OD x 7 days or ampicillin 100 mkday q6-8 x 7 days or cefixime 15 mkday x 7-10 days
Nontyphoidal Salmonella is excreted in feces for a median of __
5 weeks
Virulence factor of S. Typhi that has a protective effect against the bactericidal action of the serum of infected patients
polysaccharide capsule Vi
Infecting dose of S. Typhi
Incubation period
10^5-10^9
Incubation period 4-14 days
Macular or maculopapular rash visible around the 7th-10th day of illness, appearing in crops of 10-15 on the lower chest an abdomen and last 2-3 days. Lesion? Diagnosis?
Rose spots
Typhoid fever
Test that measures antibodies against O and H antigens of S. Typhi
Widal test
Treatment of uncomplicated typhoid fever
- Fully sensitive
- MDR
- Quinolone-resistant
- Fully sensitive: chloramphenicol 50-75 mkday x 14-21 days
or amoxicillin 75-100 mkday x14 days - MDR: fluoroquinolone 15 mkday x 5-7 days
or cefixime 15-20 mkday x 7-14 days - Quinolone-resistant: azithromycin 8-10 mkday x 7 days
or ceftriaxone 75 mkday x 10-14 days
Treatment of sever typhoid fever
- Fully sensitive
- MDR
- Quinolone-resistant
- Fully sensitive: fluoroquinolone 15 mkday x 10-14 days
- MDR: fluoroquinolone 15 mkday x 10-14 d
- Quinolone-resistant: cefriaxone 60 mkday x 10-14 days
or cefotaxime 80 mkday x 10-14 days
“Chronic carriers” are individuals who excrete S. Typhi for __
3 months or longer